Soluble HLA-I (s-HLA-I) synthesis in systemic lupus erythematosus

Rheumatology International

Volumn 23, Issue 6, 2003, Pages 294-300

  Adamashvili, Irena ^a   Wolf, Robert ^b   Aultman, Donnie ^a   Milford, Edgar L ^c   Jaffe, Stephen ^a   Hall, Vicky ^b   Pressly, Thomas ^b   Minagar, Alireza ^a   Kelley, Roger ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Louisiana State University School of Medicine Shreveport   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Enzyme linked immunosorbent assay; Major histocompatibility complex; Soluble human leukocyte antigens; Systemic lupus erythematosus

Indexed keywords

HLA A ANTIGEN; HLA A23 ANTIGEN; HLA A24 ANTIGEN; HLA A9 ANTIGEN; HLA ANTIGEN CLASS 1; SOLUBLE HLA ANTIGEN CLASS 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC HETEROGENEITY; HAPLOTYPE; HIGH RISK POPULATION; HUMAN; IMMUNOBLOTTING; LYMPHOCYTOSIS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR WEIGHT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RISK FACTOR; SERUM; SYSTEMIC LUPUS ERYTHEMATOSUS; UNITED STATES;

ADULT; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENES, MHC CLASS I; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; VARIATION (GENETICS);

EID: 0345117267     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-003-0306-3     Document Type: Article

References (42)

1. Indiveri F, Wilson BS, Natali PG, Pellegrino MA, Ferone S (1980) Immunogenicity of DR antigens isolated from body fluids. Transplant Proc 12:121
2. Koubek K (1982) Serological detection of B-cell ("la-like") antigens in serum of normal donor and in some sera of leukaemic patients. Folia Haematol Int Mag Klin Morphol Blutforsch 109:408
3. Pellegrino MA, Russo C, Allison JP (1984) HLA antigens in serum. Methods Enzymol 108:614
4. Westhoff U, Thinnes FP, Gotz H, Grosse-Wilde H (1991) Quantitation of soluble HLA class II molecules by an enzyme-linked immunosorbent assay. Vox Sang 61:106
5. Jendro M, Goronzy JJ, Weyand CM (1991) Structural and functional characterization of HLA-DR molecules circulating in the serum. Autoimmunity 8:289
6. Kao KJ, Scornik JC, McQueen CF (1988) Association between HLA phenotype and HLA concentration in plasma or platelets. Human Immunol 121:115
7. McDonald JC, Adamashvili I, Hayes JM, Aultman DR, Rhynes VK, Gelder FB (1994) Soluble HLA class II concentrations in normal individuals and transplant recipients. Comparison with soluble HLA class I concentrations. Transplantation 58:1268
8. Perosa F, Prete M, Lucarelli G, Favoino B, Ferrone B (1999) Serum levels of beta-2-microglobulin free heavy chain of HLA antigen in healthy individuals: relationship to their class II allospecificities. Hum Immunol 60:1058
9. Davies HS, Polland SG, Calne RY (1989) Soluble HLA antisens in the circulation of liver graft recipients. Transplantation 47:524
10. Claus R, Werner H, Schulze H, Walzel H, Friemel H (1990) Are soluble monocytes-derived HLA class II molecules candidates for immunosuppression activity? Immunol Lett 26:205
11. McDonald JC, Gelder FB, Aultman DR, Landreneau MD, McMillan RW, Singh I, Sorrells D, Liou WH (1992) HLA in human serum - quantitation of class I by enzyme immunoassay. Transplantation 53:445
12. Adamashvili I, McDonald J, Fraser P et al (1995) Soluble Class I HLA antigens in patients with rheumatoid arthritis and their families. J of Rheumatology 22:1025
13. Adamashvili I, McVie R, Gelder F et al (1997) Soluble HLA Class I antigens in patients with Type I diabetes and their family members. Human Immunology 55:176
14. Adamashvili E, Fraser P, McDonald J (1996) Association of serum concentrations of soluble class I HLA with HLA allotypes. Transplantation 61:984
15. Ferreira A, Villar ML, Alvarez Cermeno JC, Revilla Y, Garcia Rodriquez MC, Fontan G, Gonzaleaz-Porque P (1988) Quantification of soluble HLA class I antigens in healthy volunteers and AIDS patients. Clin Chim Acta 174:207
16. Hagihara M, Simura T, Takebe K, Munkhbat B, Hosoi K, Kagawa T, Watanabe N, Matsuzaki S, Yamamoto K, Sato K, Tsuji K (1997) Serum concentrations of soluble HLA-class I and CD8 forms in patients with viral hepatic disorders. J Gastroenterol 32:338
17. Migliaresi S, Bresciani A, Ambrosone L, Spera M, Barvarulo Lombari V, Pirozz G, Borgia G, Lombari M, Manzo TG (2000) Increased serum concentrations of soluble HLA-class I antigens: hepatitis C virus related mixed cryoglobulinemia. Ann Rheum Dis 59:20
18. Moore C, Ehlayel M, Inostroxa J, Leiva L, Kubibidizia S, Ode D, Warrier P, Sorensen R (1998) Increased circulating levels of soluble HLA class I heterodimers in patients with sickle cell disease. J Natl Med Assoc 90:157
19. Brown C, McCloskey D, Bundy D, Navarrete C (1999) Parasitic infection with trichuris trichiura influences plasma T soluble HLA class I. Human Immunol 60:1067
20. Hagihara M, Shimura T, Yamamoto K, Sujirachato K, Tsuji S, Yamamoto M, Tsuji K (1993) Clinical significance of serum soluble HLA class I antigens in systemic lupus erythematosus. Tokai J Exp Clin Med 18:61
21. Adamashvili I, McDonald J, Pressly T, Gebel H (2000) Soluble HLA (sHLA) in the saliva of patients with autoimmune diseases. Soluble MHC, immunoregulation and tolerance. Madison, Wisconsin. [Suppl]
22. Gelder F, Adamashvili I, Wolf R (1993) Distribution of soluble HLA-molecules in patients with systemic lupus erythematosus. J Immunol 150 [Suppl]: 199
23. Wolf R, Adamashvili I, Gelder F, Hall V, Fraser P, McDonald J (1998) Soluble HLA-I in rheumatic diseases. Human Immunology 59-644
24. Bresciani A, Pirozz G, Spera M, Lombardi M, Ambrosone L, Migliaresi S, Ferrone S, Manzo T (1998) Increased levels of serum HLA class I antigens in patients with systemic lupus erythematosus. Correlation with disease activity. Tissue Antigens 52:44
25. Dobbe L, Stam N, Neeffes J et al (1988) Biochemical complexity of serum HLA class I molecules. Immunogenetics 27:203
26. Krangel M (1986) Secretion of HLA-A and B antigens via an alternative RNA splicing pathway. J Exp Med 5:1173
27. Haga J, She J, Kao K (1991) Biochemical characterization of 39-kDa class I histocompatibility antigen in plasma. J Biol Chem 6:3695
28. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DHJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheumol 1271
29. Bombardier C, Gladman D, Urowiz M, Caron D, Chang C (1992) Derivation of the SLEDAL: a disease activity index for lupus patients. Arthritis Rheumol 35:630
30. Hagihara M, Hosoi K, Kagawa T, Gonsuvd B, Munkhbat B, Watanabe N, Matsuzaki S, Tsuji K (1999) Serum soluble HLA-DR antigens in autoimmune hepatitis. Autoimmunity 31:85
31. Rhyne VK, McDonald JC, Gelder FB, Aultman DF, Hayes JM, McMillan RW, Mancini MC (1993) Soluble HLA class I in the serum of transplant recipients. Ann Surg 217:485
32. Alvarez-Cermeno J, Echevarria J, Villar L, Lazaro I, Bootello A, Gonzalez-Porque P (1989) Soluble class I antigens in serum and CSF of patients with Varicella zoster virus meningitis. J Neurol Neurosurg Psychiatry 52:1194
33. Alavarez-Cermeno J, Casado C, Villar L, Ferreita A, Varela J, Dominguez M, Bootello A, Najera R, Gonzalez-Porque P (1990) Soluble class I antigens (sHLA) in CSF and serum of patients with HIV infection. Acta Neurol Scand 82:14
34. Ott M, Seidl C, Westhoff U, Stecker K, Seifried E, Fischer P, Grosse-Wilde H (1998) Soluble HLA class I and class II antigens in patients with multiple sclerosis. Tissue Antigens 51:301
35. Filaci G, Contini P, Brenci S, Gazzola P, Lanza L, Scudeletti M, Indiveri F, Manacardi G, Puppo F (1993) Soluble HLA class I and class II molecule levels in serum and cerebrospinal fluid of multiple sclerosis patients. Human Immunol 42:9
36. Kamada N, Brons G, Davies H (1980) Fully allogenic liver grafting in rats induces a state of systemic non-reactivity to donor. Transplantation 29:429
37. Claus R, Werner H, Schulze H et al (1990) Are soluble monocyte-derived HLA class II molecules candidates for immunosuppressive activity. Immunol Lett 26:203
38. McMillan R, Gelder F, Zibari G et al (1997) Soluble fraction of Class I human histocompatibility leukocyte antigens in the serum of liver transplant recipients. Clinical Transpl 11:98
39. Tsuchiya N, Shiota M, Yamaguchi A, Ito K (1996) Elevated serum level of soluble HLA class I antigens in patients with systemic lupus erythematosus. Arthritis Rheum 39:792
40. Honeyman M, Harrison I, Drummond B, Colman P, Tait B (1955) Analysis of families of risk for insulin-independent diabetes mellitus reveals that HLA antigens influence progression of clinical disease. Mol Med 1:576
41. Zavazava N, Wobst B, Ferstl R, Muller-Rochholtz W (1994) Soluble MHC class I molecules in human body fluids. J Clin Lab Analysis 8:432
42. N'Guyen C, Sodoyer R, Trucy J et al (1985) The HLA Aw24 gene: Sequence, surroundings and comparison with the HLA-A2 and HLA-A3 genes. Immunogenetics 21:479